Claes Klintenberg

1.1k total citations
26 papers, 881 citations indexed

About

Claes Klintenberg is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Claes Klintenberg has authored 26 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Cancer Research and 9 papers in Surgery. Recurrent topics in Claes Klintenberg's work include Breast Cancer Treatment Studies (7 papers), Head and Neck Cancer Studies (6 papers) and Cancer Genomics and Diagnostics (6 papers). Claes Klintenberg is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Head and Neck Cancer Studies (6 papers) and Cancer Genomics and Diagnostics (6 papers). Claes Klintenberg collaborates with scholars based in Sweden, Switzerland and United States. Claes Klintenberg's co-authors include Jan Olofsson, Bo Nordenskjöld, Lambert Skoog, Olle Stål, Christer Tagesson, Magnus Källberg, Hans Starkhammar, Henrik Hellquist, H. Sökjer and Bjørn Risberg and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Claes Klintenberg

26 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claes Klintenberg Sweden 17 356 346 236 229 211 26 881
Kichinobu Tomita Japan 13 113 0.3× 459 1.3× 377 1.6× 249 1.1× 128 0.6× 36 943
Hening Ren United States 15 227 0.6× 257 0.7× 99 0.4× 621 2.7× 56 0.3× 21 976
G Delides Greece 18 107 0.3× 254 0.7× 123 0.5× 279 1.2× 130 0.6× 51 855
Cheng‐Lung Hsu Taiwan 18 147 0.4× 364 1.1× 178 0.8× 187 0.8× 66 0.3× 46 881
Xianlu Zhuo China 17 210 0.6× 288 0.8× 138 0.6× 496 2.2× 60 0.3× 69 841
Sunandana Chandra United States 8 251 0.7× 250 0.7× 156 0.7× 348 1.5× 81 0.4× 10 642
Umberto Veronesi Italy 13 494 1.4× 345 1.0× 198 0.8× 177 0.8× 328 1.6× 37 947
Yun-Fei Xia China 21 277 0.8× 508 1.5× 213 0.9× 461 2.0× 89 0.4× 40 1.2k
Gang Peng China 16 328 0.9× 275 0.8× 279 1.2× 472 2.1× 31 0.1× 44 1.2k
Xiaoyun Jiang China 15 213 0.6× 148 0.4× 88 0.4× 521 2.3× 60 0.3× 93 980

Countries citing papers authored by Claes Klintenberg

Since Specialization
Citations

This map shows the geographic impact of Claes Klintenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claes Klintenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claes Klintenberg more than expected).

Fields of papers citing papers by Claes Klintenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claes Klintenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claes Klintenberg. The network helps show where Claes Klintenberg may publish in the future.

Co-authorship network of co-authors of Claes Klintenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Claes Klintenberg. A scholar is included among the top collaborators of Claes Klintenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claes Klintenberg. Claes Klintenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tell, Roger, Christer Sederholm, Claes Klintenberg, et al.. (2009). Multicentre phase II trial of paclitaxel and carboplatin with concurrent radiotherapy in locally advanced non-small cell lung cancer.. PubMed. 28(5B). 2851–7. 7 indexed citations
2.
Schelin, Sonny, et al.. (2009). Long-term follow-up after triple treatment of prostate cancer stage pT3. Scandinavian Journal of Urology and Nephrology. 43(3). 186–191. 3 indexed citations
3.
Sundquist, M., Sten Thorstenson, Claes Klintenberg, Lars Brudin, & Bo Nordenskjöld. (2000). Indicators of loco-regional recurrence in breast cancer. European Journal of Surgical Oncology. 26(4). 357–362. 23 indexed citations
4.
Adell, Gunnar, Xiao‐Feng Sun, Olle Stål, et al.. (1999). p53 status: an indicator for the effect of preoperative radiotherapy of rectal cancer. Radiotherapy and Oncology. 51(2). 169–174. 62 indexed citations
5.
Stål, Olle, et al.. (1997). Overexpression of c-erbB-2 protein and locoregional recurrence in node-positive breast cancer. The Breast. 6(6). 354–360. 4 indexed citations
6.
Klintenberg, Claes, et al.. (1996). Primary Radiotherapy of Tl and T2 Glottic Carcinoma: Analysis of treatment results and prognostic factors in 223 patients. Acta Oncologica. 35(sup8). 81–86. 18 indexed citations
7.
Tagesson, Christer, Magnus Källberg, Claes Klintenberg, & Hans Starkhammar. (1995). Determination of urinary 8-hydroxydeoxyguanosine by automated coupled-column high performance liquid chromatography: a powerful technique for assaying in vivo oxidative DNA damage in cancer patients. European Journal of Cancer. 31(6). 934–940. 141 indexed citations
8.
Stål, Olle, John Carstensen, Sten Wingren, et al.. (1994). Relationship of DNA Ploidy and S-Phase Fraction to Survival After First Recurrence of Breast Cancer. Acta Oncologica. 33(4). 423–429. 10 indexed citations
9.
Stål, Olle, Monika Dufmats, Thomas Hatschek, et al.. (1993). S-phase fraction is a prognostic factor in stage I breast carcinoma.. Journal of Clinical Oncology. 11(9). 1717–1722. 54 indexed citations
10.
Tytor, Maciej, et al.. (1990). Squamous cell carcinoma of the oral cavity. A review of 176 cases with application of malignancy grading and DNA measurements. Clinical Otolaryngology. 15(3). 235–252. 40 indexed citations
11.
Stål, Olle, Sten Wingren, John Carstensen, et al.. (1989). Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer. European Journal of Cancer and Clinical Oncology. 25(2). 301–309. 63 indexed citations
12.
Franzén, G, Jan Olofsson, Claes Klintenberg, & Ulf T. Brunk. (1987). Prognostic Value of Malignancy Grading and DNA Measurements in Small Glottic Carcinomas. ORL. 49(2). 73–80. 13 indexed citations
13.
Azavedo, Edward, et al.. (1987). Prognostic significance of the receptor for epidermal growth factor in human mammary carcinomas.. PubMed. 7(3 Pt B). 459–64. 58 indexed citations
14.
Klintenberg, Claes, Olle Stål, Bo Nordenskjöld, et al.. (1986). Proliferative index, cytosol estrogen receptor and axillary node status as prognostic predictors in human mammary carcinoma.. PubMed. 7 Suppl. S99–106. 62 indexed citations
15.
Franzén, G, Claes Klintenberg, Jan Olofsson, & Bjørn Risberg. (1986). DNA measurement – An objective predictor of response to irradiation? A review of 24 squamous cell carcinomas of the oral cavity. British Journal of Cancer. 53(5). 643–651. 39 indexed citations
16.
Wilhelmsson, Bo, Henrik Hellquist, Jan Olofsson, & Claes Klintenberg. (1985). Nasal Cuboidal Metaplasia with Dysplasia. Acta Oto-Laryngologica. 99(5-6). 641–648. 28 indexed citations
17.
18.
Klintenberg, Claes, et al.. (1985). DNA Distribution, Cytosol Estrogen Receptors and Axillary Nodes as Prognostic Predictors in Breast Carcinoma. Acta Radiologica Oncology. 24(3). 253–258. 22 indexed citations
19.
Skoog, Lambert, et al.. (1985). Receptors for retinoic acid and retinol in human mammary carcinomas. European Journal of Cancer and Clinical Oncology. 21(8). 901–906. 6 indexed citations
20.
Klintenberg, Claes, Jan Olofsson, Henrik Hellquist, & H. Sökjer. (1984). Adenocarcinoma of the ethmoid sinuses. A review of 28 cases with special reference to wood dust exposure. Cancer. 54(3). 482–488. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kichinobu Tomita Breakdown of academic impact, for papers by Hening Ren Breakdown of academic impact, for papers by G Delides Breakdown of academic impact, for papers by Cheng‐Lung Hsu Breakdown of academic impact, for papers by Xianlu Zhuo Breakdown of academic impact, for papers by Sunandana Chandra Breakdown of academic impact, for papers by Umberto Veronesi Breakdown of academic impact, for papers by Yun-Fei Xia Breakdown of academic impact, for papers by Gang Peng Breakdown of academic impact, for papers by Xiaoyun Jiang
Rankless by CCL
2026